Investing in the Future of Angelman Syndrome Research: FAST Partners with ASGCT to Support Early-Career Scientists
FAST partners with ASGCT to fund up to three $100,000 Career Development Awards, recruiting early-career scientists to advance neuron-targeted gene and cell therapies for Angelman syndrome.”
FAST Announces Funding For First Innovative Seed Grant
FAST has awarded its first Innovative Seed Grant to Drs. Rachel Cunningham and Jennifer Adair to develop a safer, more accessible hematopoietic stem cell therapy approach for Angelman syndrome that avoids risky chemotherapy-based conditioning.
Expanding the Pre-Clinical Research Landscape for Angelman Syndrome
FAST currently manages over 20 active research grants for Angelman syndrome and is expanding its infrastructure by broadening its Scientific Advisory Board and streamlining its grants management system.